Greece
Subsections:
1. Lifetime Prevalence of Drug Use
"Preliminary data provided by the University Mental Health Research Institute (UMHRI) regarding the most recent survey (2004) show that 8.6% of the Greek population aged 12-64 reported lifetime use of illicit drugs, mainly cannabis. The lifetime drug use ratio between men and women is 3 to 1. The highest prevalence is met in the age group 18-35 and in the Greater Athens area as compared with the second largest city (Thessaloniki), the other urban, and the semi-urban and rural areas." "2005 National Report to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: University Mental Health Research Institute, 2005), p. 14. |
2. Lack of Current Data on Prevalence of Use Within General Population in Greece "General population data based on probabilistic sampling have been available at almost regular intervals (every 5 years) already since the mid-1980s from the surveys conducted first by the Psychiatric Clinic of the Athens University Medical School and later by the UMHRI. Moreover, the methodology of the latest survey conducted by UMHRI in 2004 was fully harmonised with the EMCDDA standards for surveys (see www.emcdda.europa.eu/themes/ke...), thereby permitting comparability between the situation in Greece and the situation in other European countries. It is noted, however, that since 2004 there has been no repeat survey of a representative general population sample." University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 29. |
3. Prevalence of Illicit Drug Use Among Youth in Greece, 2011 "According to the most recent data (2011): University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 30. |
4. Prevalence and Frequency of Cannabis Use Among Youth in Greece, by Gender "More students have repeated cannabis use (3 times or more; 7.8%) than they have only used 1-2 times (5.6%). Boys repeated cannabis use in significantly higher proportions compared to girls (11.1% and 4.4%, respectively). Repeated cannabis use (as opposed to 1-2 times use) increases after the age of 16. Finally, students in Athens and Thessaloniki repeat cannabis use in significantly higher proportions compared to other areas (10.6%, 11.1%, and 5.4%, respectively) (Table 2.2)." University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 31. |
5. Trends in Prevalence of Cannabis Use Among Youth "Over time, with the exception of cannabis, there is no significant variation in the lifetime prevalence of any substance use. For cannabis in particular, following the decline recorded from 2002 to 2006, prevalence rates increased between 2006 and 2010 (Figure 2.3), with the increase being significant only among boys. University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), p. 20. |
6. Prevalence of Illicit Drug Use Among Youth Compared With Other EU Nations "According to preliminary data from the 2010 HBSC survey published in the EMCDDA annual report (EMCDDA, 2011), in recent years (2006-2010) there has been an overall stable or decreasing trend in cannabis use in many countries. However, increases have been recorded not only in Greece, but also in the Czech Republic, Latvia, Lithuania, Romania and Slovenia. University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), p. 21. |
7. Prevalence of Illicit Drug Use Among Greek Youth Compared with Other EU Nations "Furthermore, according to the Eurobarometer survey findings, young people in Greece compared to the European / EU27 average: University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), pp. 21-22. |
8. Charges Brought for Drug-Related Offenses in Greece, 2010 "Every year the Greek REITOX Focal Point collects from the Central Anti-drug Coordination Unit – National Intelligence Unit (SODN-EMP) data on charges brought for drug-related offences. In 2010, the Greek DPAs23 brought 13,176 charges against 12,805 individuals for drug use, production / cultivation, dealing / trafficking and other drug-related offences (see ST11). As shown in Figure 9.1, the decline in both the number of individuals charged with drug-related offences and the number of drug-related cases observed in the three-year period 2005-2007 reappeared in the years 2009-2011. More specifically, the number of individuals returned to the levels of 2004 and the number of cases to the levels of 2006-2007." University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 126. |
9. Convictions for Drug-Related Crimes in Greece, 2009 "The Hellenic Statistical Authority (ELSTAT) is responsible for collecting data from the judicial services on the number of individuals convicted for drug-related offences and reports them to the Greek REITOX Focal Point on a yearly basis. The latest available data are for the year 2009 (Figure 9.2). Of a total of 45 127 convicts, 1 818 (4.0%) were convicted for drug-related crimes. The overwhelming majority (96.3%, ?=1 751) are men. 1 222 individuals (67.2%) were convicted for drug use, possession or cultivation of a small quantity for personal use, 520 individuals were convicted for drug use, dealing and trafficking (28.6%), 61 individuals for drug dealing and trafficking (3.4%), and 15 individuals for drug cultivation / production (0.8%). Figure 9.3 shows the distribution of convicts by gender and drug-related offence in the four-year period 2005-2009. In the period under consideration there has been no significant variation in the distribution of convicts by gender and drug-related offence. University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), pp. 127-128. |
10. Sentences for Drug Convictions in Greece, 2009 "The maximum sentences imposed for drug use, possession or cultivation of a small quantity for personal use is prison sentences of one year. Of the sentences imposed for drug trafficking / dealing, the total of penalties are prison sentences for a term or for life. Similarly, the sentences imposed for drug cultivation / production are non-commutable prison sentences exceeding five years. The sentences imposed for drug use, dealing and trafficking are prison sentences exceeding one year, and 99.4% of them are prison sentences for a term or for life. University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 129. |
11. Prevalence of Problem Drug Use in Greece, 2011 "The probable number of problem drug users in Greece continues to be estimated every year by the internationally recommended 'capture-recapture' method, based on the annual data from the University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 55. |
12. Rise in Problem Drug Use in Greece Attributable to Eurozone Economic Downturn "According to the latest data from the Greek Documentation and Monitoring Centre for Drugs, the number of persons with problematic drug use (heroin as the primary addictive substance) rose by 11.6% between 2008 and 2010 (from 20,181 cases in 2008 to 22,515 cases in 2010)53,54; among those aged 35 to 64 years, the increase was far more intense at 88.2% (from 4875 cases in 2008 to 9176 cases in 2010). Taking into account that in 2010 the average age for initiation of injection drug use was estimated at 22.4 years old,54 this sharp increase of older heroin users in Greece indicates probable relapses rather than new cases, presumably associated with the ongoing economic downturn." E. Kondilis, et al., "Economic Crisis, Restrictive Policies, and the Population’s |
13. HIV Prevalence and Injection Drug Use in Greece "According to KEELPNO [Hellenic Center for Disease Control and Prevention] (2012), throughout the recent years no more than 20 cases which had IDU as a probable source of transmission were reported annually in Greece (Figure 6.1). IDUs never represented more than 2–3% of all total reported cases (Figure 6.2). In 2011, a total of 256 HIV cases were attributed to injecting drug use, with this route of transmission representing 26.8% of all reported cases that year (Figure 6.1 and Figure 6.2). Between January 1st and August 31st 2012, 768 HIV cases have already been recorded in KEELPNO’s surveillance system, 314 of which (40.8%) were reported as IDU cases (Figure 6.1 and Figure 6.2) (Nikolopoulos 2012). University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), pp. 92-93. |
14. Evidence of Rising Prevalence of HIV Among IDUs in Greece "In 2011, data on serological and behavioural indicators were collected on a total of 2,329 IDUs (not accounting for double counts; data from 63 out of the 70 sites in the DRID [Drug Related Infectious Diseases] network). The number of tests conducted in 2011 in the three different data and the demographic characteristics of the IDUs tested are presented in Table 6.2 and Table 6.3, respectively. University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 94. |
15. Impact of the Eurozone Economic Downtown on IDU-Related HIV "Trends in infectious diseases hold particular interest. Whereas tuberculosis incidence continued its declining trend (according to the Hellenic Centre for Disease Control and Prevention, reported new cases of tuberculosis decreased by 26.8% between 2007 and 2010),55 Greece surprisingly faced 3 infectious disease outbreaks in a period of less than 18 months, between July 2010 and December 2011: an outbreak of West Nile virus infection in northern Greece between July and October 2010, including 197 patients with neuroinvasive disease and 35 deaths56; an outbreak of malaria in southern Greece between May and October 2011, including 63 cases, of which 40 reported no travel history to endemic countries57; and worsening trends in HIV infection between 2010 and 2011, such as a 57.2% increase in newly diagnosed cases of HIV-1 infection (from 607 new cases in 2010 to 954 cases in 2011) and a 1506.7% increase of newly diagnosed cases of HIV-1 infection among injection drug users (from 15 cases in 2010 to 241 cases in 2011).58 E. Kondilis, et al., "Economic Crisis, Restrictive Policies, and the Population’s |
16. Hepatitis C Prevalence and Injection Drug Use in Greece "According to DRID data, HCV antibody prevalence in IDUs has been consistently high and increasing over the last 10 years in Greece. In 2011, prevalence rates ranged between 62.4% and 79.3%, depending on the source of data (Figure 6.4). Compared to 2010, in 2011 HCV infection rates remained stable in data source 1 (national sample), but increased significantly in data sources 2 (national sample) and 3 (Athens sample) (Figure 6.4)." University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 96. |
17. Treatment Service Availability in Greece, 2011 "In 2011, a total of 92 treatment units offered drug treatment in Greece: 42 OST units (33 buprenorphine and 9 providing mainly methadone); 43 drug-free treatment programmes (11 inpatient/adults; 19 outpatient/adults, 12 outpatient/adolescents; and 1 detoxification unit) (Figure 5.1); and 7 drug-free treatment programmes for imprisoned and released drug users (see Chapter 9 for prison data). University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), pp. 59-61. |
18. Treatment Utilization in Greece, 2011 "In 2011, the total capacity of the treatment units (main treatment phase) was 7,853 slots (data for 75 of the 78 treatment units) (Figure 5.2). Most of the treatment slots were offered in OST units (6,789, 86.5%, Figure 5.10), and 13.5% (1,064, Figure 5.5) were offered by drug-free treatment programmes. Compared to 2010, in 2011 the treatment capacity increased by 18.8%, sustaining the increasing trend observed in the entire 2002-2011 period (Figure 5.2), which is a direct consequence of the increasing number of treatment units over the years (Figure 5.1). University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 61. |
19. Clients Entering Treatment, Primary Drug, and Outcomes "Most of the clients (6,754) report opioids as their primary drug, followed at a great distance by cannabis (243) and cocaine (93) (data for 57 of the 61 structures). Injecting use prior to admission was reported by 4,192 clients in treatment in the reporting year (data for 55 of the 61 structures). Out of “all clients”, 2,400 (32.3%) are aged over 40 (data for 59 of the 61 structures). University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), p. 48. |
20. Opioid Substitution Treatment (OST) in Greece, Capacity and Client Data "42 OST units currently operate in Greece of which nine (9) methadone substitution units and thirty-three (33) buprenorphine substitution units. Only OKANA provides substitution treatment services. University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), pp. 68-70. |
21. Growth in Treatment Capacity "In the period 2002-2010, the capacity of treatment programmes steadily increased. Figure 5.2 illustrates this increase, which is a direct consequence of the increasing number of treatment structures over the years. Similarly, the number of “all clients” in treatment per year increased, as demonstrated by the sum of clients already in treatment and “admissions” (3,745 in 2002 versus 8,067 in 2010). University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), p. 48. |
22. National Drug Strategy
"The National Plan against Addictions for the period 2011-2012, which was prepared by the Committee, takes into consideration the constraints imposed by the economic crisis and consequent fiscal austerity and attempts to streamline expenditure. University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), pp. 11-12. |
23. National Plan Against Addictions "The National Plan against Addictions for the period 2011-2012, which was prepared by the Committee, takes into consideration the constraints imposed by the economic crisis and consequent fiscal austerity and attempts to streamline expenditure. The main goals of the National Plan in the field of demand reduction (with a special reference to treatment) are the following6: University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), pp. 43-44. |
24. Expansion, New Initiatives, and the Economic Crisis "Hope in 2010 went hand in hand with the awareness that the economic crisis was deepening and fiscal austerity would spread. The increase in the number of units and the increase in the number of clients in treatment, doubled by the decrease in staff and pay cuts, indicated that the system was already overstretched and could take no more tension. University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), pp. xiii-ix. |
25. Greek Drug Law Reform "The most important developments in the drugs legislation were introduced in 2011. University Mental Health Research Institute, "2011 National Report (2010 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2011), p. 2. |